CHINARES PHARMA (03320): China Resources Double-Crane Pharmaceutical's net profit attributable to the parent company in 2025 was 1.647 billion yuan, a year-on-year increase of 1.18%.

19:08 19/03/2026

China Resources Pharmaceutical (03320) announced the annual performance of China Resources Sanjiu Corporation Limited (China Resources Sanjiu) ending December 31, 2025. The total operating income was 11.001 billion yuan, a year-on-year decrease of 1.88%, and the net profit attributable to shareholders of the listed company was 1.647 billion yuan, a year-on-year increase of 1.18%. The basic earnings per share were 1.5949 yuan. It is proposed to distribute a cash dividend of 3.79 yuan (including tax) per 10 shares.

CHINARES PHARMA (03320) announced the annual performance of China Resources Double-Crane Pharmaceutical Co., Ltd. (China Resources Double-Crane Pharmaceutical) as of December 31, 2025. The total operating income was RMB 11.001 billion, a decrease of 1.88% year-on-year, and the net profit attributable to shareholders of the listed company was RMB 1.647 billion, an increase of 1.18% year-on-year. Basic earnings per share were RMB 1.5949. It is proposed to distribute a cash dividend of RMB 3.79 (tax included) per 10 shares.

SIS MOBILE (01362) announces 2025 performance, net profit of HK$6,634,000, a year-on-year decrease of 32.42%.

CNBM(03323): Sinoma Science & Technology (002080.SZ) achieved a net profit attributable to the parent company of 1.818 billion yuan in 2025, a year-on-year increase of 103.82%.

NOAH HOLDINGS (06686) spent approximately $376,000 on March 18 to repurchase 162,520 shares.

SIS MOBILE (01362) announces 2025 performance, net profit of HK$6,634,000, a year-on-year decrease of 32.42%.

CNBM(03323): Sinoma Science & Technology (002080.SZ) achieved a net profit attributable to the parent company of 1.818 billion yuan in 2025, a year-on-year increase of 103.82%.

NOAH HOLDINGS (06686) spent approximately $376,000 on March 18 to repurchase 162,520 shares.